Vancomycin-intermediate Staphylococcus aureus in Korea

J Clin Microbiol. 2000 Oct;38(10):3879-81. doi: 10.1128/JCM.38.10.3879-3881.2000.

Abstract

Recent reports on some methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin have been a major concern in Korea because of the widespread use of vancomycin due to a high prevalence of MRSA in the country. We describe a 45-year-old man with long-standing pelvic abscess due to MRSA. In spite of vancomycin and teicoplanin treatment for a long period of time, the patient died from MRSA sepsis. The blood culture isolate of MRSA exhibited reduced susceptibility to vancomycin (MIC, 8 microg/ml). This is the first report of a vancomycin-intermediate S. aureus case from Korea.

Publication types

  • Case Reports

MeSH terms

  • Abdominal Abscess / microbiology*
  • Drug Resistance, Microbial*
  • Drug Therapy, Combination / therapeutic use*
  • Fatal Outcome
  • Humans
  • Korea
  • Male
  • Methicillin Resistance
  • Microbial Sensitivity Tests
  • Middle Aged
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / microbiology*
  • Staphylococcus aureus / drug effects*
  • Staphylococcus aureus / isolation & purification*
  • Teicoplanin / therapeutic use*
  • Vancomycin / pharmacology*
  • Vancomycin / therapeutic use*

Substances

  • Teicoplanin
  • Vancomycin